Purchases and Sales Made in Q4 2024 in Adc Therapeutics Sa (ADCT)
This table provides information about the institutional ownership of Adc Therapeutics Sa (ADCT) during Q4 2024. The information is specifically focused on institutions that hold shares of ADC Therapeutics SA.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 29, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-1.59K- 1.43% |
$3.01K - $5.54K
|
110K
$297K
|
|
Feb 14, 2025
Q4 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-1.61K- 6.35% |
$3.05K - $5.61K
|
23.8K
$64.2K
|
|
Feb 14, 2025
Q4 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-2.49K- 0.02% |
$4.7K - $8.65K
|
15.7M
$42.3M
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-2.74K- 21.23% |
$5.18K - $9.55K
|
10.2K
$27.5K
|
|
Feb 14, 2025
Q4 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-4.84K- 1.01% |
$9.16K - $16.9K
|
476K
$1.29M
|
|
Jan 16, 2025
Q4 2024
|
Dlk Investment Management, LLC
Solana Beach, CA |
SELL
|
- |
-7.35K- 22.17% |
$13.9K - $25.6K
|
25.8K
$69.7K
|
|
Feb 13, 2025
Q4 2024
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-12K- 27.78% |
$22.6K - $41.7K
|
31.1K
$84K
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-15.4K- 0.91% |
$29.1K - $53.7K
|
1.67M
$4.52M
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-41.8K- 53.03% |
$79K - $145K
|
37K
$100K
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-62K- 25.29% |
$117K - $216K
|
183K
$495K
|
|
Feb 14, 2025
Q4 2024
|
Prosight Management, LP
Dallas, TX |
SELL
|
- |
-121K- 1.26% |
$229K - $422K
|
9.52M
$25.7M
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-301K- 42.29% |
$569K - $1.05M
|
411K
$1.11M
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-1.21M- 48.31% |
$2.28M - $4.2M
|
1.29M
$3.49M
|